BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

  March 20, 2026

   · 

  22 min read
• Press Releases

  Ultima Genomics Announces UG200 Series Selected for Basecamp Research’s Groundbreaking Trillion Gene Atlas

  March 20, 2026

   · 

  3 min read
• Press Releases

  BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

  March 20, 2026

   · 

  2 min read
• Press Releases

  Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at ECO 2026

  March 20, 2026

   · 

  5 min read
• Press Releases

  D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session

  March 20, 2026

   · 

  4 min read
• Press Releases

  GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer

  March 20, 2026

   · 

  1 min read
• Press Releases

  Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

  March 20, 2026

   · 

  6 min read
• Press Releases

  Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

  March 20, 2026

   · 

  5 min read
• Press Releases

  Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program

  March 20, 2026

   · 

  2 min read
• Press Releases

  The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®

  March 20, 2026

   · 

  5 min read